An end to end approach to managing wearable devices through clinical development.
As the industry moves forward to using more Real World Evidence and virtual / decentralized trials, digital endpoints will become a necessity. Pre-register to receive our whitepaper which will explore why digital endpoints are important, and the benefits they can have for a trial or drug/device development plan.
We explore a framework for successful digital transformation including:
The whitepaper will explore the challenges and weaknesses in using digital endpoints and how can they be addressed, how digital endpoints can be successfully incorporate in a trial or observational study, and how to make data clinical relevant and credible for regulatory bodies.
Available mid-June. Pre-register now to receive on publication.